CLDN6 and endometrial carcinoma: Normally silent in adult endometrium, CLDN6 was found to be highly expressed in a subset of endometrial carcinomas, and high CLDN6 significantly associated with advanced FIGO stage (III/IV), lymph vascular invasion, positive lymph nodes, and distant metastasis (65).